| Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients N Lallous, SV Volik, S Awrey, E Leblanc, R Tse, J Murillo, K Singh, ... Genome biology 17, 1-15, 2016 | 241 | 2016 |
| Human bocavirus infections in hospitalized children and adults J Longtin, M Bastien, R Gilca, E Leblanc, G De Serres, MG Bergeron, ... Emerging infectious diseases 14 (2), 217, 2008 | 212 | 2008 |
| Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening. NA Lack, P Axerio-Cilies, P Tavassoli, FQ Han, KH Chan, C Feau, ... Journal of medicinal chemistry 54 (24), 8563-8573, 2011 | 186 | 2011 |
| Global genetic diversity of human metapneumovirus fusion gene G Boivin, I Mackay, TP Sloots, S Madhi, F Freymuth, D Wolf, ... Emerging infectious diseases 10 (6), 1154, 2004 | 178 | 2004 |
| Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo JB Lee, K Zhang, YYC Tam, YK Tam, NM Belliveau, VYC Sung, PJC Lin, ... International Journal of Cancer 131 (5), E781-E790, 2012 | 165 | 2012 |
| Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor H Li, F Ban, K Dalal, E Leblanc, K Frewin, D Ma, H Adomat, PS Rennie, ... Journal of medicinal chemistry 57 (15), 6458-6467, 2014 | 151 | 2014 |
| Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer K Dalal, M Roshan-Moniri, A Sharma, H Li, F Ban, M Hessein, M Hsing, ... Journal of biological chemistry 289 (38), 26417-26429, 2014 | 145 | 2014 |
| Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons R Gilca, G De Serres, M Tremblay, ML Vachon, E Leblanc, MG Bergeron, ... The Journal of infectious diseases 193 (1), 54-58, 2006 | 141 | 2006 |
| Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp. A Rochette, F McNicoll, J Girard, M Breton, É Leblanc, MG Bergeron, ... Molecular and biochemical parasitology 140 (2), 205-220, 2005 | 138 | 2005 |
| Best practices of computer-aided drug discovery: lessons learned from the development of a preclinical candidate for prostate cancer with a new mechanism of action F Ban, K Dalal, H Li, E LeBlanc, PS Rennie, A Cherkasov Journal of chemical information and modeling 57 (5), 1018-1028, 2017 | 127 | 2017 |
| Toxic colors: the use of deep learning for predicting toxicity of compounds merely from their graphic images M Fernandez, F Ban, G Woo, M Hsing, T Yamazaki, E LeBlanc, ... Journal of chemical information and modeling 58 (8), 1533-1543, 2018 | 110 | 2018 |
| Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening P Axerio-Cilies, NA Lack, MRS Nayana, KH Chan, A Yeung, E Leblanc, ... Journal of medicinal chemistry 54 (18), 6197-6205, 2011 | 110 | 2011 |
| Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole … RSN Munuganti, E Leblanc, P Axerio-Cilies, C Labriere, K Frewin, ... Journal of medicinal chemistry 56 (3), 1136-1148, 2013 | 96 | 2013 |
| Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer RSN Munuganti, MDH Hassona, E Leblanc, K Frewin, K Singh, D Ma, ... Chemistry & biology 21 (11), 1476-1485, 2014 | 83 | 2014 |
| Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3) F Ban, E Leblanc, H Li, RSN Munuganti, K Frewin, PS Rennie, ... Journal of medicinal chemistry 57 (15), 6867-6872, 2014 | 64 | 2014 |
| Human parainfluenza type 4 infections, Canada ML Vachon, N Dionne, E Leblanc, D Moisan, MG Bergeron, G Boivin Emerging infectious diseases 12 (11), 1755, 2006 | 63 | 2006 |
| Pterin and Folate Reduction by theLeishmania tarentolaeH Locus Short-Chain Dehydrogenase/Reductase PTR1 J Wang, É Leblanc, CF Chang, B Papadopoulou, T Bray, JM Whiteley, ... Archives of biochemistry and biophysics 342 (2), 197-202, 1997 | 60 | 1997 |
| Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer K Dalal, F Ban, H Li, H Morin, M Roshan-Moniri, KJ Tam, A Shepherd, ... Cancer letters 437, 35-43, 2018 | 59 | 2018 |
| Changes in folate and pterin metabolism after disruption of the Leishmania H locus short chain dehydrogenase gene. B Papadopoulou, G Roy, W Mourad, E Leblanc, M Ouellette Journal of Biological Chemistry 269 (10), 7310-7315, 1994 | 59 | 1994 |
| Infections by human coronavirus-NL in hospitalized children G Boivin, M Baz, S Côté, R Gilca, C Deffrasnes, É Leblanc, MG Bergeron, ... The Pediatric infectious disease journal 24 (12), 1045-1048, 2005 | 57 | 2005 |
Artem CherkasovUniversity of British Columbia在 interchange.ubc.ca 的电子邮件经过验证
